Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) closed the day trading at $460.00 down -1.06% from the previous closing price of $464.92. In other words, the price has decreased by -$1.06 from its previous closing price. On the day, 0.97 million shares were traded. VRTX stock price reached its highest trading level at $465.18 during the session, while it also had its lowest trading level at $458.55.
Ratios:
For a better understanding of VRTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.26 and its Current Ratio is at 2.52. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Barclays on August 05, 2024, Downgraded its rating to Equal Weight and sets its target price to $509 from $472 previously.
On June 27, 2024, Redburn Atlantic started tracking the stock assigning a Buy rating and target price of $545.
Evercore ISI Upgraded its In-line to Outperform on April 11, 2024, while the target price for the stock was maintained at $438.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 30 ’24 when LEIDEN JEFFREY M sold 3,784 shares for $499.00 per share. The transaction valued at 1,888,216 led to the insider holds 9,994 shares of the business.
Bhatia Sangeeta N. sold 646 shares of VRTX for $323,000 on Aug 30 ’24. The Director now owns 4,435 shares after completing the transaction at $500.00 per share. On Aug 30 ’24, another insider, Bhatia Sangeeta N., who serves as the Director of the company, bought 646 shares for $500.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRTX now has a Market Capitalization of 118726918144 and an Enterprise Value of 113864916992. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.50 while its Price-to-Book (P/B) ratio in mrq is 8.03. Its current Enterprise Value per Revenue stands at 11.015 whereas that against EBITDA is 25.908.
Stock Price History:
Over the past 52 weeks, VRTX has reached a high of $510.64, while it has fallen to a 52-week low of $341.85. The 50-Day Moving Average of the stock is -4.67%, while the 200-Day Moving Average is calculated to be 4.43%.
Shares Statistics:
Over the past 3-months, VRTX traded about 1.15M shares per day on average, while over the past 10 days, VRTX traded about 1009000 shares per day. A total of 257.70M shares are outstanding, with a floating share count of 257.43M. Insiders hold about 0.26% of the company’s shares, while institutions hold 92.69% stake in the company. Shares short for VRTX as of 1724976000 were 4380989 with a Short Ratio of 3.81, compared to 1722384000 on 5080317. Therefore, it implies a Short% of Shares Outstanding of 4380989 and a Short% of Float of 1.7000000000000002.
